Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Overweight 1Metabolic Syndrome 1Insulin Resistance 1Infertility 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 456Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Has results × Ethinyl Estradiol × Clear all
NCT02729545 2019-10-08

The Efficacy and Safety Study of Tung's Acupuncture for Polycystic Ovarian Syndrome

Beijing Hospital of Integrated Traditional Chinese and Western Medicine

Phase 2 Completed
60 enrolled 14 charts

Polycystic Ovary Syndrome

NCT00442689 2014-06-06

Metabolic Syndrome in PCOS: Precursors and Interventions

Northwestern University

Phase NA Completed
97 enrolled 13 charts

Infertility, Insulin Resistance, Polycystic Ovary Syndrome, Metabolic Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡